Literature DB >> 4162449

Polymorphonuclear leukocytes in immunologic reactions. The destruction of vascular basement membrane in vivo and in vitro.

C G Cochrane, B S Aikin.   

Abstract

Vascular basement membrane was disrupted in the presence of polymorphonuclear leukocytes (PMN's) during two immunologic reactions: The Arthus phenomenon and the reaction to locally injected antibody to vascular basement membrane. This disruption was evidenced by (a) the inability of the basement membrane to retain circulating carbon, by (b) loss of antigenic constituents, and by (c) electron microscopic observation showing actual gaps in the structure of the vascular basement membrane. The factors within PMN's responsible for damage to isolated glomerular basement membrane in vitro were found by isolation procedures to be cathepsins D and E. Cationic proteins of PMN's were separable from the cathepsins. While inducing vascular permeability upon injection, these basic proteins failed to inflict the severe damage to the basement membrane observed in Arthus and antibasement membrane reactions. It is concluded that the full expression of these immunologic lesions requires destruction of the basement membrane possibly brought about by cathepsins D and E. Some of the physicochemical properties of these pathologically active leukocytic factors are given.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4162449      PMCID: PMC2138252          DOI: 10.1084/jem.124.4.733

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  36 in total

1.  A PERMEABILITY FACTOR RELEASED FROM LEUKOCYTES AFTER PHAGOCYTOSIS OF IMMUNE COMPLEXES AND ITS POSSIBLE ROLE IN THE ARTHUS REACTION.

Authors:  H Z MOVAT; T URIUHARA; D L MACMORINE; J S BURKE
Journal:  Life Sci (1962)       Date:  1964-09

2.  SOME ELECTRON MICROSCOPIC OBSERVATIONS ON INTERACTIONS BETWEEN LEUKOCYTES, PLATELETS, AND ENDOTHELIAL CELLS IN ACUTE INFLAMMATION.

Authors:  V T MARCHESI
Journal:  Ann N Y Acad Sci       Date:  1964-08-27       Impact factor: 5.691

3.  THE DELAYED AND PROLONGED VASCULAR LEAKAGE IN INFLAMMATION. II. AN ELECTRON MICROSCOPIC STUDY OF THE VASCULAR RESPONSE AFTER THERMAL INJURY.

Authors:  R S COTRAN
Journal:  Am J Pathol       Date:  1965-04       Impact factor: 4.307

4.  The passage of colloidal particles across the dermal capillary wall under the influence of histamine.

Authors:  J F ALKSNE
Journal:  Q J Exp Physiol Cogn Med Sci       Date:  1959-01

5.  The biochemical basis of phagocytosis. I. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes.

Authors:  A J SBARRA; M L KARNOVSKY
Journal:  J Biol Chem       Date:  1959-06       Impact factor: 5.157

6.  Pathogenesis of serum sickness.

Authors:  F J DIXON; J J VAZQUEZ; W O WEIGLE; C G COCHRANE
Journal:  AMA Arch Pathol       Date:  1958-01

7.  Factors leading to variation in concentration of nephrotoxic antigen(s) of glomerular basement membrane.

Authors:  C A KRAKOWER; S A GREENSPON
Journal:  AMA Arch Pathol       Date:  1954-11

8.  Morphology of vascular permeability. I. Passive cutaneous anaphylaxis.

Authors:  R D PETERSON; R A GOOD
Journal:  Lab Invest       Date:  1962-07       Impact factor: 5.662

9.  A ROLE OF POLYMORPHONUCLEAR LEUKOCYTES AND COMPLEMENT IN NEPHROTOXIC NEPHRITIS.

Authors:  C G COCHRANE; E R UNANUE; F J DIXON
Journal:  J Exp Med       Date:  1965-07-01       Impact factor: 14.307

10.  The role of polymorphonuclear leukocytes in the initiation and cessation of the Arthus vasculitis.

Authors:  C G COCHRANE; W O WEIGLE; F J DIXON
Journal:  J Exp Med       Date:  1959-09-01       Impact factor: 14.307

View more
  69 in total

Review 1.  Role of granulocytes in immune complex-induced tissue injuries.

Authors:  C G Cochrane
Journal:  Inflammation       Date:  1977-12       Impact factor: 4.092

2.  Inhibition of the local hemorrhagic Shwartzman reaction by an acid proteinase.

Authors:  T Y Lin; H R Williams
Journal:  Experientia       Date:  1975-02-15

3.  Tubulointerstitial immune complex nephritis in a patient with systemic lupus erythematosus: role of peritubular capillaritis with immune complex deposits in the pathogenesis of the tubulointerstitial nephritis.

Authors:  Satoshi Hayakawa; Kimimasa Nakabayashi; Miho Karube; Yoshihiro Arimura; Yoshiro Arimura; Akinori Soejima; Akira Yamada; Yasunori Fujioka
Journal:  Clin Exp Nephrol       Date:  2006-06       Impact factor: 2.801

Review 4.  PMN adhesion and extravasation as a paradigm for tumor cell dissemination.

Authors:  C W Smith; D C Anderson
Journal:  Cancer Metastasis Rev       Date:  1991-05       Impact factor: 9.264

Review 5.  Optimisation of cyclophosphamide therapy in systemic vasculitis.

Authors:  R Richmond; T W McMillan; R A Luqmani
Journal:  Clin Pharmacokinet       Date:  1998-01       Impact factor: 6.447

Review 6.  Tissue factor in crescentic glomerulonephritis.

Authors:  R T McCluskey
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

7.  [The regulation of acute inflammatory processes by systemic changes of plasma protein profiles].

Authors:  R Scherer; G Ruhenstroth-Bauer
Journal:  Naturwissenschaften       Date:  1977-09

8.  Hypertonic saline resuscitation of hemorrhagic shock diminishes neutrophil rolling and adherence to endothelium and reduces in vivo vascular leakage.

Authors:  José L Pascual; Lorenzo E Ferri; Andrew J E Seely; Giuseppina Campisi; Prosanto Chaudhury; Betty Giannias; David C Evans; Tarek Razek; René P Michel; Nicolas V Christou
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

9.  Human vascular smooth muscle cells and endothelial cells lack catalase activity and are susceptible to hydrogen peroxide.

Authors:  M Shingu; K Yoshioka; M Nobunaga; K Yoshida
Journal:  Inflammation       Date:  1985-09       Impact factor: 4.092

10.  Anti-inflammatory effect of LA 2851 and reference drugs on some models of inflammation. Investigation of the mechanism of action.

Authors:  J L Junien; C Lakatos; J Brohon; M Guillaume; J Sterne
Journal:  Agents Actions       Date:  1982-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.